drugset
drugset / Trial / NCT01172691

Trial of Inhaled Nitric Oxide (iNO) on Ischemia / Reperfusion Injury During Orthotopic Liver Transplantation With Marginal Grafts

NCT01172691 ↗

Phase 2 Completed 23 enrolled Baylor Research Institute Mallinckrodt · collab
RandomizedParallel-groupTriple-blindPrevention

Summary

This study is being done to determine if patients receiving (iNO) will have increased liver function and less damage from IR than patients who do not receive (iNO).

Timeline

Start
2010-07
Primary completion
2014-01-22
Completion
2014-01-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitric Oxide Other / unclassified 40 ppm Inhaled

Indications

No indication recorded.